[1]Krishnamurthy A,Vijayalakshmi N,Majhi U.A fatal case of pure giant cell carcinoma of the lung［J］.J Cancer Res Ther,2011,7（3）:363-365.
[2]Alasio TM,Sun W,Yang GC.Giant cell carcinoma of the lung impact of diagnosis and review of cytological features［J］.Diagn Cytopathol,2007,35(9):555-559.
[3]Ishibashi H,Akamatsu H,Sunamori M,et al.Gingival metastasis of pulmonary pleomorphic carcinoma:Report of a case［J］.Kyobu Geka,2005,58(5):410-414.
[4]Xu CC,Gui Q,Fu XN.Adenocarcinoma combined with giant cell carcinoma of the lung:A case report and review of literature［J］.Cancer Research on Prevention and Treatment,2011,38（6）:729-730.［徐澄澄，桂琦，付向宁.肺腺癌合并巨细胞癌1例及文献复习［J］.肿瘤防治研究，2011，38（6）:729-730.］
[5]Fishback NF,Travis WD,Moran CA,et al.Pleomorphic(spindle/giant cell) carcinoma of the lung.A clinicopathologic correlation of 78 cases［J］.Cancer,1994,73(12):2936-2945.
[6]Rossi G,Cavazza A,Sturm N,et al.Pulmonary carcinomas with pleomorphic,sarcomatoid,or sarcomatous elements:A clinicopathologic and immunohistochemical study of 75 cases［J］.Am J Surg Pathol,2003,27(3):311-324.
[7]Travis WD,Brambilla E,Müller-Hermelink HK,et al.World health organization classification of tumors:Pathology and genetics of tumors of the lung,pleura,thymus and heart ［M］.Lyon:IARC Press,2004:26-67.
[8]Kodama T,Miyazaki K,Satoh H,et al.Giant cell lung carcinoma in a man with acquired immunodeficiency syndrome［J］.Med Oncol,2009,26(2):167-169.
[9]Oncale M,Kimbrell HZ,Barnhill M,et al.Antemortem diagnosis of likely giant cell carcinoma of the lung by pleural fluid cytology evaluation［J］.Ochsner J,2015,15(2):196-199.
[10]Jiang WY,Fu XN,Liao YD,et al.Analysis of giant cell carcinoma of the lung:6 cases review［J］.Journal of Clinical Pulmonary Medicine,2012,17(2):358.［江文洋，付向宁，廖永德，等.肺巨细胞癌6例分析［J］.临床肺科杂志，2012，17(2):358.］
[11]Choi HS,Seol H,Heo IY,et al.Fine-needle aspiration cytology of pleomorphic carcinomas of the lung［J］.Korean J Pathol,2012,46(6):576-582.
[12]Ito K,Oizumi S,Fukumoto S,et al.Clinical characteristics of pleomorphic carcinoma of the lung［J］.Lung Cancer,2010,68(2):204-210.
[13]Rashid S,Rajan D,Jacob R,et al.Colonic metastases from pleomorphic carcinoma of the lung presenting as an ileocecal intussusception［J］.Gastroenterol,2011,2011:137139.
[14]Ouziane I,Boutayeb S,Mrabti H,et al.Sarcomatoid carcinoma of the lung:A model of resistance of chemotherapy［J］.N Am J Med Sci,2014,6(7):342-345.
[15]Schaefer IM,Sahlmann CO,Overbeck T,et al.Blastomatoid pulmonary carcinosarcoma:Report of a case with a review of the literature［J］.BMC Cancer,2012,12:424.
[16]Weissferdt A,Moran CA.Malignant biphasic tumors of the lungs［J］.Adv Anat Pathol,2011,18(3):179-189.
[17]Kim TS,Han J,Lee KS,et al.CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients［J］.AJR Am J Roentgenol,2005,185(1):120-125.
[18]You Yonghao,Liu Rongting,Li Ming.Two cases report of giant cell carcinoma of the lung and literature review［J］.Modern Oncology,2012,20(12):2641.［游永浩，刘荣婷，李鸣.肺巨细胞癌2例报告及文献复习［J］.现代肿瘤医学，2012，20(12):2641.］
[19]Hiroshima K,Dosaka-Akita H,Usuda K,et al.Cytological characteristics of pulmonary pleomorphic and giant cell carcinomas［J］.Acta Cytol,2011,55(2):173-179.
[20]Zhao ZL,Song N,Huang QY,et al.Clinicopathologic features of lung pleomorphic（spindle/giant cell) carcinoma-a report of 17 cases［J］.Chin J Cancer,2007,26(2):183-188.
[21]Lin Y,Yang H,Cai Q,et al.Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma［J］.Am J Clin Oncol,2016,39（3）:215-222.
[22]Xiong WJ,Zhang XX,Huang MJ,et al.Outcomes of treatment of 32 cases of advanced or relapsed post-surgery pulmonary sarcomatoid carcinoma［J］.J Sichuan Univ(Med Sci Edi),2014,45(2):320-323.［熊伟杰，张新星，黄媚娟，等.32例晚期及术后复发肺肉瘤样癌患者的治疗及生存分析［J］.四川大学学报（医学版），2014,45(2):320-323.］
[23]Xu WJ,Huang C,Wang LC,et al.Characteristics and prognostic analysis of 47 patients with lung sarcomatoid carcinoma［J］.Chinese Journal of Clinical Oncology,2008,35(18):1045-1049.［徐文静，黄纯，王柳春，等.47例肺肉瘤样癌的特征及预后因素分析［J］.中国肿瘤临床，2008,35(18):1045-1049.］
[24]Italiano A,Cortot AB,Ilie M,et al.EGFR and KRAS status of primary sarcomatoid carcinomas of the lung:Implications for anti-EGFR treatment of a rare lung malignancy［J］.Int J Cancer,2009,125(10):2479-2482.
[25]Venissac N,Pop D,Lassalle S,et al.Sarcomatoid lung cancer（spindle/giant cells):An aggressive disease［J］? J Thorac Cardiovasc Surg,2007,134(3):619-623.
[26]Vieira T,Duruisseaux M,Ruppert AM,et al.Pulmonary sarcomatoid carcinoma［J］.Bull Cancer,2012,99(10):995-1001.
[27]Jiang X,Liu Y,Chen C,et al.The value of biomarkers in patients with sarcomatoid carcinoma of the lung:Molecular analysis of 33 cases［J］.Clin Lung Cancer,2012,13(4):288-296.
[28]Nie XM,Bai CG,Sun QY,et al.Effects of gefitinib in treatment of sarcomatoid carcinoma of lung:A case report and literature review［J］.Chin J Respir Crit Care Med,2012,11(2):172-174.［聂小蒙，白辰光，孙沁莹，等.吉非替尼治疗肺肉瘤样癌一例及文献复习［J］.中国呼吸与危重监护杂志，2012,11(2):172-174.］
[29]Leone A,Graziano P,Gasbarra R,et al.Identification of EGFR mutations in lung sarcomatoid carcinoma［J］.Int J Cancer,2011,128(3):732-735.
[30]Kaira K,Horie Y,Ayabe E,et al.Pulmonary pleomorphic carcinoma:A clinicopathological study including EGFR mutation analysis［J］.J Thorac Oncol,2010,5(4):460-465.
[31]Ferrara N.Binding to the extracellular matrix and proteolytic processing:Two key mechanisms regulating vascular endothelial growth factor action［J］.Mol Biol Cell,2010,21(5):687-690.
[32]Zheng X,Sun BC,Zhao XL,et al.Relationship between vasculogenic mimicry and epithelial-to-mesenchymal transition in pulmonary sarcomatoid carcinoma［J］.Chinese Journal of Clinical Oncology,2013,40(8):431-433.［郑旭，孙保存，赵秀兰，等.肺肉瘤样癌中血管生成拟态的形成及其与上皮间充质转化的关系［J］.中国肿瘤临床，2013，40（8）：431-433.］
[33]Qin SK,Li J.Apatinib for clinical application,expert consensus for the treatment of gastric cancer［J］.Chinese Clinical Oncology,2015,20(9):841-847.［秦叔逵，李进.阿帕替尼治疗胃癌的临床应用专家共识［J］.临床肿瘤学杂志,2015,20(9):841-847.］